胸肌下丛阻滞增强多节段胸椎旁阻滞用于原发性乳腺癌手术的麻醉效果:前瞻性随机双盲研究
本研究纳入60例在6节段胸椎旁阻滞(6m-TPVB)下接受原发性乳腺癌手术的患者,随机分为胸肌下丛阻滞(SPPB)组和假阻滞组。结果显示SPPB组术中需要氯胺酮补救镇痛的患者比例(56.7% vs 93.3%,p=0.002)及氯胺酮用量中位数(10 mg vs 50 mg,p<0.001)均显著低于假阻滞组,外科医生满意度也更高(77.29±10.63 vs 65.83±21.38,p=0.02)。结论认为SPPB可增强6m-TPVB的麻醉效果。
要点
- 6m-TPVB联合SPPB可减少乳腺癌术中补救镇痛需求。
- SPPB组氯胺酮补救镇痛比例56.7%,假阻滞组93.3%。
- SPPB组氯胺酮用量中位数10 mg,假阻滞组50 mg。
核心结论
- 胸肌下丛阻滞(SPPB)可增强6节段胸椎旁阻滞(6m-TPVB)用于原发性乳腺癌手术的麻醉效果。
研究设计与样本
- 前瞻性随机双盲研究,60例在6m-TPVB下接受原发性乳腺癌手术的患者随机分为SPPB组(Gp-A,n=30)和假阻滞组(Gp-B,n=30)。
主要发现
- SPPB组需要氯胺酮补救镇痛的患者比例为56.7%,显著低于假阻滞组的93.3%(p=0.002)。
- SPPB组氯胺酮用量中位数为10 mg(IQR 0-40),显著低于假阻滞组的50 mg(IQR 20-70)(p<0.001)。
- 外科医生对手术条件的满意度评分SPPB组为77.29±10.63,显著高于假阻滞组的65.83±21.38(p=0.02)。
- 两组在人口学数据、咪达唑仑和右美托咪定总剂量、手术时长及患者总体满意度方面具有可比性。
关键数值与推荐
- 6m-TPVB在T1-T6每个椎体水平注射4-5 mL 0.5%罗哌卡因(含1:200 000肾上腺素),总容量25 mL。
- SPPB在第三肋水平、胸肩峰动脉起点附近分别于胸肌前锯肌平面和胸肌间平面各注射5 mL 0.25%罗哌卡因。
- 假阻滞组在胸大肌内注射3-5 mL生理盐水。
- 麻醉开始前静脉给予咪达唑仑1-3 mg和氯胺酮10-20 mg镇静镇痛,术中持续输注右美托咪定0.1-0.5 mcg/kg/h维持清醒镇静。
- 术中疼痛时静脉给予氯胺酮10-20 mg补救镇痛,最大累计100 mg,若麻醉 deemed inadequate 则转为全身麻醉。
临床怎么用
- 对于接受6m-TPVB下原发性乳腺癌手术的患者,可考虑联合SPPB以改善术中麻醉效果并减少补救镇痛需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The efficacy of a multilevel thoracic paravertebral block (6m-TPVB at T1-T6), as the sole anesthetic, for primary breast cancer surgery (PBCS) has been questioned. Current literature suggests that a significant number of patients may report pain during various stages of surgery, notably during the detachment of the breast base from the pectoralis major muscle and its fascia. Given that the pectoral muscles are innervated by nerves from the subpectoral plexus (C5-T1), which are not affected by a 6m-TPVB alone, we propose that an additional "subpectoral plexus block" (SPPB) may enhance the surgical anesthesia. METHODS: 60 patients undergoing PBCS under a 6m-TPVB were randomized to receive an SPPB (Gp-A, n=30) or a sham block (Gp-B, n=30). Midazolam (1-3 mg) and ketamine (10-20 mg) were administered intravenously for sedation and analgesia before the block placement and an infusion of dexmedetomidine (0.1-0.5 mcg/kg/h) was used to maintain conscious sedation during surgery. The 6m-TPVB was ultrasound guided, and 4-5 mL of 0.5% ropivacaine with 1:200 000 epinephrine was injected at each vertebral level (total volume used 25 mL). The SPPB was also ultrasound guided, and 5 mL of 0.25% ropivacaine was injected each near the origin of the thoracoacromial artery in the pectoserratus plane and between the two pectoral muscles (interpectoral plane) in Gp-A, at the level of the third rib. In Gp-B, 3-5 mL of normal saline (sham block) was injected into the pectoralis major muscle. Surgery commenced about 25-30 min after the completion of the SPPB. Ketamine (10-20 mg IV bolus) was used for rescue analgesia (our primary outcome variable) if the patient complained of pain during surgery to an arbitrary maximum of 100 mg, or the anesthesia was deemed inadequate, after which it was converted to general anesthesia. RESULTS: The two study groups were comparable with respect to demographic data, total dose of midazolam and dexmedetomidine used, duration of surgery, and overall patient satisfaction. Ketamine, as rescue analgesia, was required to complete surgery in both study groups, but fewer patients in Gp-A (56.7%) required rescue analgesia than in Gp-B (93.3%, p=0.002). Ketamine requirement (median (IQR)) was also significantly lower (p<0.001) in Gp-A (10 (0-40) mg) than in Gp-B (50 (20-70) mg). The surgeons were more (p=0.02) satisfied (mean±SD numeric rating scale, 0-100) with surgical conditions in Gp-A (77.29±10.63) than in Gp-B (65.83±21.38). CONCLUSION: A SPPB enhances the surgical anesthesia produced by a 6m-TPVB for primary breast cancer surgery. TRIAL REGISTRATION NUMBER: https://www.chictr.org.cn/showprojEN.html?proj=5368, Trial ID No: ChiCTR-TRC-14004200; Date of Registration: 25 January 2014, Study commencement date: 28 February 2014.
引用
- Karmakar MK, Pakpirom J, Songthamwat B, et al. Subpectoral plexus block to enhance surgical anesthesia produced by a multilevel thoracic paravertebral block for primary breast cancer surgery: a prospective randomized double-blind study. Reg Anesth Pain Med. 2026. PMID: 39900452. doi:10.1136/rapm-2024-106126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。